Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluorometholone is a synthetic glucocorticoid corticosteroid primarily used as an ophthalmic suspension to treat inflammation of the eye caused by surgery, injury, or other conditions. It acts by inhibiting the inflammatory response in ocular tissues such as the conjunctiva and cornea. The drug reduces swelling by suppressing immune system activity and limiting processes like edema formation, leukocyte migration, capillary dilation and proliferation, fibroblast proliferation, collagen deposition, and scar formation. Fluorometholone is available only with a prescription and is supplied under several brand names for topical ophthalmic use. Developed and manufactured by Allergan, fluorometholone exerts its effects by acting as an agonist of the glucocorticoid receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluorometholone.